U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  5. FDA Grand Rounds: The Scientific Basis of Proposed Tobacco Product Standards to Prohibit Menthol as a Characterizing Flavor in Cigarettes and Flavors in Cigars - 01/12/2023
  1. FDA Grand Rounds

Webcast

Event Title
FDA Grand Rounds: The Scientific Basis of Proposed Tobacco Product Standards to Prohibit Menthol as a Characterizing Flavor in Cigarettes and Flavors in Cigars
January 12, 2023

Date:
January 12, 2023
Time:
12:00 PM - 1:00 PM ET
Image
Grand Rounds 1292022

About the Speaker

Bridget K. Ambrose, Ph.D., MPH
Director
Division of Population Health Science (DPHS)
Office of Science (OS)
Center for Tobacco Products (CTP)

Dr. Bridget Ambrose serves as the Director of the Division of Population Health Science in the Office of Science at the Center for Tobacco Products. She has over twenty years of experience in tobacco control and regulatory science, with specialized experience in longitudinal analyses of tobacco use.  Dr. Ambrose was a founding member of the management team responsible for designing and launching the Population Assessment of Tobacco and Health (PATH) Study.  Her research interests include understanding the role characterizing flavors play in promoting tobacco use among young people, as well as the potential role of characterizing flavors in promoting switching from combustible to non-combustible tobacco use.  Dr. Ambrose received her PhD in Epidemiology from Johns Hopkins University in 2011.  

About the Presentation

On April 28, 2022, the Food and Drug Administration (FDA) announced proposed product standards to prohibit menthol as a characterizing flavor in cigarettes and prohibit all characterizing flavors (other than tobacco) in cigars. These actions have the potential to significantly reduce disease and death from combusted tobacco product use, the leading cause of preventable death in the U.S., by reducing youth experimentation and addiction, and increasing the numbers of smokers that quit.  This presentation will provide an overview of the scientific evidence that informed the development of these proposed rules, with an explanation of the external peer review process FDA utilized for review of the highly influential scientific assessments for these proposed rules.

Learning Objectives

  1. Discuss the public health burden of combusted tobacco product use
  2. Describe the major conclusions of the scientific assessments developed by FDA to inform the proposed product standards
  3. Discuss the steps involved in the external peer review of the Agency’s scientific assessments

Webcast Recording:

https://fda.zoomgov.com/rec/share/pGhvzajo177iDGrB8gj9Uy5Wp0BmAolVumbsvbq40vAt16ent9PFjWRsjcGqCBo.Fk_dHRbwFbIW5CNX

Event Materials: 

Activity Outline FDA Grand Rounds: January 12, 2023
 

Back to Top